Novo Nordisk CEO Mike Doustdar particulars the corporate’s Amazon partnership, advantages of Ozempic past weight reduction and extra on ‘The Claman Countdown.’
Novo Nordisk’s oral variations of its blockbuster weight-loss medication, Ozempic and Wegovy, at the moment are accessible for same-day supply on Amazon.
Novo Nordisk CEO Mike Doustdar mentioned on “The Claman Countdown” Friday the once-daily tablet variations of the corporate’s extremely fashionable therapies have been a significant success.
“It’s an thrilling time, I’d say, for the sufferers that may get entry to those merchandise when they need it and as quick as doable,” he instructed FOX Enterprise.
“I believe it is very nice that, proper now, folks can have each Ozempic injection, in addition to Ozempic tablet.”
FIRST GLP-1 PILL FOR WEIGHT LOSS, DIABETES SHOWS SUCCESS IN LATE-PHASE TRIAL
Amazon is now providing same-day supply of Novo Nordisk’s Ozempic tablet. (Left (Justin Sullivan/Getty Photos), Proper (Michael Siluk/UCG/Common Photos Group by way of Getty Photos) / Getty Photos)
The Ozempic tablet launched final week, following the January debut of an oral model of Wegovy, which has delivered robust outcomes, producing greater than $350 million in first-quarter gross sales.
“This has been one of the best product launch within the final decade that we’ve seen. And I am extremely excited,” Doustdar mentioned. “We have now seen in 16 weeks time, since we’ve launched it, a couple of million sufferers [who] have tried it.”
Ozempic is prescribed for sufferers with Kind 2 Diabetes, whereas Wegovy is used to deal with weight problems. Each therapies have been initially made as weekly injectables, however the newer oral variations are a once-daily tablet.
HHS SEC ROBERT F KENNEDY JR: AMERICAN PATIENTS PAY MORE SO OTHERS CAN PAY LESS — THAT STOPS NOW
“I’d say Wegovy’s tablet would be the one which would be the flagship, however the Ozempic tablet on the again of an iconic model title, in fact, may also discover its good area,” Doustdar mentioned.
Mike Doustdar, chief govt officer of Novo Nordisk A/S, on the Novo Nordisk A/S annual basic assembly in Copenhagen, Denmark, on Thursday, March 26, 2026. (Nichlas Pollier/Bloomberg by way of Getty Photos / Getty Photos)
Novo Nordisk was one of many first to work with the Trump administration to decrease the prices of prescribed drugs and Doustdar mentioned decreasing costs was necessary to make sure truthful entry.
“We have been very completely satisfied that we have been in a position to make a take care of the Trump administration, and primarily as a result of our job is to actually guarantee that these modern drugs get entry, and so they do not grow to be a product only for the wealthy. They grow to be the product for everybody,” the CEO mentioned.
“I’d say decrease costs have offered us with extra sufferers and extra quantity. Whereas quick time period, that is hurting our enterprise. Long term, it is the appropriate factor to do.”
Whereas Ozempic and Wegovy are identified for inducing weight reduction, Doustdar highlighted the medication’ broader advantages for cardiovascular, kidney and liver well being – most notably, their potential to treatment scarring in sufferers with fatty liver illness.
Picture illustration of injectable prescription weight reduction medication Ozempic on a weight scale. (Picture by: Michael Siluk/UCG/Common Photos Group by way of Getty Photos) (Michael Siluk/UCG/Common Photos Group by way of Getty Photos) / Getty Photos)
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
He additionally teased the potential launch of a brand new drug therapy that proves so efficient for liver illness that it may scale back the necessity for liver transplants.
“We have now to complete the scientific improvement of it, we’ve to get it accepted. But when the early knowledge holds, then I am very optimistic,” Doustdar mentioned.
